文献速递腹部泌尿生殖MR

乏脂肪血管平滑肌脂肪瘤与透明细胞肾细胞癌的鉴别:动脉自旋标记MR成像的定性与定量分析

Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

这项前瞻性研究纳入29例透明细胞肾细胞癌和9例乏脂肪血管平滑肌脂肪瘤患者,术前行3T动脉自旋标记MR成像。透明细胞肾细胞癌的肿瘤血流量及肿瘤-皮质比、肿瘤-髓质比均显著高于乏脂肪血管平滑肌脂肪瘤,三者AUC分别为0.931、0.964、0.900;定性分析中乏脂肪血管平滑肌脂肪瘤信号强度等于或略低于肾髓质,透明细胞肾细胞癌高于肾皮质。作者结论为动脉自旋标记MR成像在定性和定量分析上均能较好鉴别两者。

要点

  • 定量参数:透明细胞肾细胞癌肿瘤血流量270.49±78.88 ml/100 g/min,高于乏脂肪血管平滑肌脂肪瘤的146.68±47.21 ml/100 g/min(P<0.01)。
  • 肿瘤-皮质比透明细胞肾细胞癌1.22±0.26 vs 乏脂肪血管平滑肌脂肪瘤0.74±0.14,肿瘤-髓质比3.13±0.94 vs 1.77±0.55(P<0.05)。
  • 定性判读:乏脂肪血管平滑肌脂肪瘤信号强度等于或略低于肾髓质,透明细胞肾细胞癌信号强度高于肾皮质。

核心结论

  • 动脉自旋标记MR成像在定性和定量分析上均能较好地将乏脂肪血管平滑肌脂肪瘤与透明细胞肾细胞癌鉴别开来。

研究设计与样本

  • 前瞻性研究,纳入29例透明细胞肾细胞癌患者和9例乏脂肪血管平滑肌脂肪瘤患者,签署书面知情同意书后于术前行3T常规解剖MRI和动脉自旋标记成像。
  • 在动脉自旋标记灌注图上沿目标病灶边缘放置感兴趣区测量肿瘤血流量,并以对侧正常肾皮质和髓质区大于10体素的簇作为参考感兴趣区计算肿瘤-皮质比和肿瘤-髓质比。
  • 由两名放射科医生共同分析动脉自旋标记图像,将肿瘤主要信号强度与肾皮质信号强度比较分为低于、相同或高于三类;采用独立样本t检验、Fisher精确检验和ROC曲线进行统计分析。

关键影像表现/征象

  • 定性分析中,乏脂肪血管平滑肌脂肪瘤的信号强度等于或略低于肾髓质。
  • 定性分析中,透明细胞肾细胞癌的信号强度高于肾皮质。

诊断标准与关键数值

  • 肿瘤血流量鉴别乏脂肪血管平滑肌脂肪瘤与透明细胞肾细胞癌的AUC为0.931。
  • 肿瘤-皮质比鉴别两者的AUC为0.964,肿瘤-髓质比鉴别两者的AUC为0.900。
  • 三个定量参数的AUC值之间无显著差异,每个参数均获得相应的最佳截断值。

临床应用与阅片要点

  • 阅片时可利用动脉自旋标记灌注图测量肿瘤血流量及肿瘤-皮质比、肿瘤-髓质比,作为鉴别乏脂肪血管平滑肌脂肪瘤与透明细胞肾细胞癌的定量参考。
  • 定性判读时注意乏脂肪血管平滑肌脂肪瘤信号强度等于或略低于肾髓质,而透明细胞肾细胞癌信号强度高于肾皮质。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the diagnostic effectiveness of arterial spin labeling (ASL) MR imaging in differentiating fat-poor AML from clear cell renal cell carcinoma (ccRCC).

METHODS: In this prospective study, 29 ccRCC patients and 9 fat-poor AML patients underwent routine anatomical MRI and ASL at 3T before surgery after signing written informed consent form. For each tumor, tumor blood flow (TBF) was measured in a region of interest (ROI) which was positioned to outline the edge of the target lesions on ASL perfusion maps. Additionally, the mean TBF values were obtained by standardizing the TBF using a blood flow measurement in the reference ROI. Moreover, a cluster containing more than 10 voxels was chosen from the renal cortex and medulla area in normal contralateral kidney as a reference ROI to calculate tumor-to-cortex ratio and tumor-to-medulla ratio. Independent sample t test was used to examine the alteration among the groups of fat-poor AML and ccRCC. ASL images were together analyzed by two radiologists to assess the following characteristics of the renal mass: predominant SI in the tumor on ASL images was lower than, as same as, or higher than SI of the cortex. For qualitative variables, Fisher's exact test was employed to compare the proportions of these two groups. The sensitivity, specificity ,and accuracy required for discrimination of fat-poor AML from ccRCC were quantified using receiver operating characteristic (ROC) curve. The corresponding optimal cutoff value was obtained for each parameter as well.

RESULTS: The TBF value was significantly higher in ccRCC group than that in fat-poor AML (270.49 ± 78.88 ml/100 g/min vs. 146.68 ± 47.21 ml/100 g/min; P < 0.01). Both tumor-to-cortex and tumor-to-medulla ratios were notably higher in ccRCC group compared with those in fat-poor AML group (1.22 ± 0.26 vs. 0.74 ± 0.14, 3.13 ± 0.94 vs. 1.77 ± 0.55; P < 0.05). The values of area under the ROC curve (AUC) for TBF, tumor-to-cortex ratio, and tumor-to-medulla ratio were 0.931, 0.964, and 0.900, respectively. No significant difference in AUC values among these three measurements was observed. For qualitative variables, the SI of fat-poor AML was equal to or slightly lower than that of renal medulla and the SI of ccRCC was found to be higher than renal cortex in ASL.

CONCLUSION: ASL MRI performs well in differentiating fat-poor AML from ccRCC in both qualitative and quantitative analyses.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Ye J, Xu Q, Wang SA, et al. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging. Abdom Radiol (NY). 2020. PMID: 31705246. doi:10.1007/s00261-019-02303-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。